HHS
House Passes Reconciliation Package; Senate Considering Changes
On May 22, the House of Representatives passed their reconciliation package, the One Big Beautiful Bill Act (H.R.1), in a 215-214 vote. The bill included sweeping cuts to Medicaid and Medicare, the Supplemental Nutrition Assistance Program (SNAP), and other welfare programs to pay for President Trump’s new tax plan as well as additional funding for immigration enforcement and border security. As previously reported by COSSA, the budget reconciliation process has been controversial, even among Republican members of Congress. Representatives Thomas Massie (R-KY) and Warren Davidson (R-OH) were the only two Republicans to vote against the “big, beautiful bill.” Representative Andy Harris (R-MD) voted…
Congress Hosts HHS Secretary Kennedy for FY 2026 Budget Hearings
As the fiscal year (FY) 2026 appropriations process gets underway, Congress invited Robert F. Kennedy Jr., Secretary of Health and Human Services (HHS), to defend the agency’s budget request in both chambers (see previous COSSA coverage). On May 14, the House Labor, Health and Human Services, and Education (LHHS) Appropriations Subcommittee and the Senate Health, Education, Labor, and Pensions (HELP) Committee held separate hearings while the Senate LHHS Appropriations Subcommittee held their respective hearing on May 20. In both chambers, Congress raised concerns over FY 2025, questioning Secretary Kennedy on whether the agency is withholding funding that has been appropriated by Congress, which…
Welch, Baldwin Host Two-Day Forum to Spotlight How Americans are Harmed by Trump’s HHS Actions
Senators Peter Welch (D-VT) and Tammy Baldwin (D-WI) held a two-day forum to spotlight how Americans are being harmed by the Trump Administration’s mass firings at the Department of Health and Human Services (HHS). This comes after the Senators hosted a similar townhall on Trump and Musk’s Cuts to Cancer and Alzheimer’s Disease Cures (see previous COSSA coverage). During the two-day forum, Sens. Welch and Baldwin invited former federal agencies officials, including Dr. Anne Schuchat, former Principal Deputy Director at the Centers for Disease Control and Prevention (CDC), Ms. Trina Dutta, former Chief of Staff at the Substance Abuse and Mental Health…
Trump Administration Releases Preliminary Details on FY 2026 Budget
On May 3, the Trump Administration released preliminary, high-level details of its fiscal year (FY) 2026 budget request, referred to as a “skinny budget,” and accompanying fact sheets. In the preliminary request, the Trump Administration reiterates its commitment to “reducing waste” and “improving efficiency” through targeting programs that support diversity, equity, and inclusion (DEI) initiatives, climate change, green energy, and other topics that have been deemed “woke” by the Administration. Full budget details are expected in the upcoming weeks. As reported in the leaked Health and Human Services (HHS) passback, the budget proposes $27 billion for the National Institutes of Health (NIH), a…
Leaked HHS Passback Budget Includes NIH Reorganization, Cuts to Health Agencies
On April 10, the Department of Health and Human Services (HHS) passback budget was leaked to the public. A passback budget is a preliminary proposal in which Federal Agencies and the White House Office of Management and Budget (OMB) negotiate discretionary funding and legislative priorities for inclusion in the Presidential Budget Request (PBR). It should not be considered the final version to be included in the PBR when it is released. Notable provisions within the leaked passback: The Presidential Budget Request (PBR) is rumored to be released in May with the possibility of a skinny budget sooner. Stay tuned to COSSA’s continued coverage on…
NIH Director Bhattacharya Gives First Public Remarks at NIH Council of Councils
On April 21, the National Institutes of Health (NIH) Director Jay Bhattacharya presented his vision for NIH during a meeting of the NIH Council of Councils. The Council consists of approximately 30 members, selected from the various NIH Institute and Center (IC) Advisory Councils, representatives nominated by the Office of the Director program offices, and broad lay representation. It advises the NIH Director on matters related to the policies and activities of the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI). As previously reported by COSSA, Bhattacharya was confirmed as NIH Director in late March. During his first public remarks since being confirmed,…
Senate Confirms Bhattacharya as NIH Director and Kratsios as OSTP Director
On March 26, the Senate voted to confirm Dr. Jay Bhattacharya as the next Director of the National Institutes of Health (NIH) in a 53-47 vote (see previous COSSA coverage). In his confirmation hearing, Dr. Bhattacharya confirmed that he would prioritize chronic disease research over infectious disease research, aligning with Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., as well as investing in cutting edge research. The Senate also confirmed Michael Kratsios as the Director of the White House Office of Science and Technology Policy (OSTP) in a bipartisan 74-25 vote (see previous COSSA coverage). Kratsios served…
NIH Director Nominee, Dr. Bhattacharya, Voted Through HELP Committee; CDC Nomination Pulled
On March 13, the nomination of Dr. Jay Bhattacharya advanced through the Senate Health, Education, Labor, and Pensions (HELP) Committee in a 12-11 vote along party lines, overcoming the first hurdle for being confirmed as the National Institutes of Health (NIH) Director (see previous COSSA coverage). The next step is a confirmation vote by the full Senate, which has not yet been scheduled. During his confirmation hearing on March 5, Bhattacharya stated an intent to refocus NIH’s research efforts on addressing chronic diseases, aligning with Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr, as well as investing in cutting…
Dorothy Fink Chosen to Serve as Acting HHS Secretary; Appoints Matthew Memoli as Acting NIH Director
Dorothy Fink M.D. has been appointed by President Trump to serve as acting Secretary of Health and Human Services (HHS) as confirmation hearings for the presidential nominee for the position, Robert F. Kennedy Jr., continue. Fink previously served as Deputy Assistant Secretary for Women’s Health and Director of the Office on Women’s Health in the Office of the Assistant Secretary for Health (OASH). Shortly after her appointment, Fink tapped Matthew Memoli, M.D., to serve as acting Director of the National Institutes of Health (NIH) as the Senate works to confirm Jay Bhattacharya (see previous COSSA coverage). Memoli, a National Institute of Allergy and…
House LHHS Appropriations Subcommittee Holds NIH Budget Hearing
On November 19, the House Labor, Health, and Human Services, Education (LHHS) Appropriations Subcommittee invited Dr. Monica Bertagnolli, Director of the National Institutes of Health (NIH) to the Hill for a budget hearing. Normally, these hearings are scheduled prior to the appropriations bills being written—typically in the spring—but the House Appropriations Committee released their LHHS bill in July without holding a single hearing (see COSSA’s analysis here). Despite the unusual sequence of events, Chairman Robert Aderholt (R-AL) and Ranking Member Rosa DeLauro (D-CT) were interested in the NIH’s budget and investments, and how to restore trust in science. Chairman Aderholt,…
House Oversight Probes Biden-Harris Administration’s Scientific Integrity Committees
On November 14, House Committee on Oversight and Accountability Chairman James Comer (R-KY) announced an investigation into the Biden-Harris Administration’s scientific integrity committees, including for the U.S. Environmental Protection Agency (EPA) and the U.S. Department of Health and Human Services (HHS). Comer cited concerns of interference of the “executive agency of future presidential administrations” through the Biden-Harris Administration’s Presidential Memorandum directing the White House Office of Science and Technology Policy (OSTP) to develop a Task Force on Scientific Integrity and federal agencies to produce scientific integrity reports (see previous COSSA coverage here). In letters sent to the EPA and HHS, Comer requested information on the…
HHS Requests Comments on Revision of Research Misconduct Policies
The Department of Health and Human Services (HHS) has released a request for information (RFI) on a proposed revision of the Public Health Service (PHS) Policies on Research Misconduct within the Office of Research Integrity (ORI) in the Office of the Assistant Secretary for Health (OASH). This policy has not been updated since its creation in 2005 and HHS expects to update the policy to clarify confidentiality requirements and revise definitions of various terms that were not previously defined in the original policy. Comments are requested by December 5 and can be submitted here.
National Academies Hosting Workshop Encouraging Greater Science Accessibility
On November 30 through December 1, the National Academies of of Sciences, Engineering, and Medicine will be hosting a public workshop aiming to provide crucial insights and recommendations to the National Institutes of Health (NIH) and other agencies within the Department of Health and Human Services (HHS). This two-day event is set to address topics surrounding scholarly publications and key focus areas of the workshop include promoting equity in publication, enhancing accessibility, addressing publication and increasing transparency of research. The National Academies invites all interested parties to participate and contribute to this vital conversation. For more information and to register,…
ARPA-H Announces New Program ARPANET-H
The Advanced Research Projects Agency for Health (ARPA-H) within the U.S. Department of Health and Human Services (HHS) announced a new nationwide health network, ARPANET-H. Within ARPANET-H, three research hubs have been developed, including the Customer Experience hub, the Investor Catalyst hub, and the Stakeholder and Operations hub. Notably, the Customer Service hub priorities include developing accessible health solutions and diversifying health solutions. The Investor Catalyst hub priorities include transforming innovative ideas into tangible solutions and the Stakeholder and Operations hub will focus on agency and stakeholder partnerships. Stay tuned to COSSA’s continued coverage of ARPA-H.
HHS Proposes New Rule to Prevent Discrimination Against Individuals with Disabilities
The Office for Civil Rights (OCR) within the U.S. Department of Health and Human Services (HHS) has proposed a new rule, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance, to prohibit discriminatory practices against individuals with disabilities. The new rule intends to expand upon Section 504 of the Rehabilitation Act of 1973. It would clarify already existing protections and implement new conditions within this act, including: HHS is requesting public comment on the proposed rule that can be submitted here. Comments are requested by November 13.
HHS Scientific Integrity Policy Public Comment Request Released
The Department of Health and Human Services (HHS) has released a draft of its Scientific Integrity Policy and is inviting the public to share feedback and comments. The draft policy is in response to the Presidential Memorandum on Restoring Trust in Government Through Scientific Integrity and Evidence-based Policymaking. Its main objective is to offer agency stakeholders an opportunity to voice their opinions on the policy. HHS formulated the draft following the guidelines from the National Science and Technology Council Framework for Federal Scientific Integrity Policy and Practice. The deadline for submissions is September 1, 2023. For additional details on the draft and how to…
Adam H. Russell Named ARPA-H Acting Deputy Director
On May 25, Secretary of the Department of Health and Human Services (HHS) Xavier Becerra formally announced the establishment of the Advanced Research Project Agency for Health (ARPA-H) within the National Institutes of Health (NIH) along with the appointment of Adam H. Russell, Ph.D. as the Acting Deputy Director of ARPA-H. Russell comes to ARPA-H from the University of Maryland’s Applied Research Laboratory for Intelligence and Security and brings more than a decade of experience as a Program Manager at the Intelligence Advanced Research Projects Agency (IARPA) and the Defense Advanced Research Projects Agency (DARPA). Russell also has an extensive…
White House Compiles Federal Equity Action Plans
The White House has published a list of equity action plans that have been developed by various federal agencies in order to comply with President Biden’s Executive Order on Advancing Racial Equity and Support for Underserved Communities Through the Federal Government (E.O. 13985) issued on the first day of his term (see previous coverage for more details). According to the White House announcement, more than 90 federal agencies across the government were consulted to contribute to the equity action plans to address where barriers to accessing federal programs may exist and identify changes to federal policy that could be made….
HHS Bypasses CDC in COVID-19 Data Collection, Sparking Concerns
On July 10, the Department of Health and Human Services (HHS) released new guidance that instructed hospitals to bypass the Centers for Disease Control and Prevention (CDC) in reporting COVID-19 data and instead send the information directly to the Department through a relatively new system called HHS Protect. The change has raised concerns among many public health and science stakeholder groups that it could signal an effort to sideline the CDC in responding to the pandemic and to limit the data available to the public. Prior to the change, hospitals submitted COVID-19 information to the CDC’s National Healthcare Safety Network…
Alex Azar, Former Pharmaceutical Executive, Nominated to Lead HHS
President Trump has nominated Alex Azar to lead the U.S. Department of Health and Human Services (HHS), which would include oversight of the National Institutes of Health (NIH) and the Agency for Healthcare Research and Quality (AHRQ), among other federal agencies. Azar served as general counsel and deputy secretary to the Department under the George W. Bush administration and served as the president of Lilly Co., part of the pharmaceutical company Eli Lilly and Co., until earlier this year. Azar’s nomination comes following former HHS Secretary Tom Price’s resignation after news surfaced of improper use of private jets for government…